Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Pharma
Novo's Wegovy scores key cardiovascular label expansion
The drug is the first weight loss treatment to win FDA approval to reduce the risk of severe cardio outcomes.
Zoey Becker
Mar 8, 2024 3:51pm
Pfizer, Astellas, Takeda, Innovent and more—Fierce Pharma Asia
Jan 12, 2024 8:15am
JPM24: Amgen CEO prepared to wade into the obesity ring
Jan 9, 2024 8:17am
Lilly hits out against using Zepbound for ‘cosmetic weight loss’
Jan 5, 2024 6:00am
Lilly makes website to simplify access to obesity drug Zepbound
Jan 4, 2024 11:42am
The top 10 Fierce Pharma Marketing stories of 2023 recapped
Dec 21, 2023 5:00am